infectious-diseases

Documents about infectious-diseases

• Surveillance of Streptococcal Infections in Children in India#369884ClinicalTrials.gov
• Modeling epidemiological patterns of smallpox in Copenhagen in the 19th century after the introduction of the vaccine#379868bioRxiv / medRxiv
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP#383620ClinicalTrials.gov
• Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies#387186ClinicalTrials.gov
• Early Innate Immune Signatures Imprint Clinical Outcomes of Bordetella pertussis Challenge in a Controlled Human Infection Model#401693bioRxiv / medRxiv
• Operating characteristics of analysis methods for clinical trials in viral respiratory disease: A simulation study protocol#407687bioRxiv / medRxiv
• M13 phage-based antigen presentation and immune response activation in vaccine development for animal infectious diseases.#415428NCBI PubMed Central
• Scaling Safe Resident Driven OPAT bundle in a Lower Middle-Income Country: A Quality Improvement Intervention#481627bioRxiv / medRxiv
• Critical environmental justice and the Wasteocene: Oppression and resistance in an Italian prison during the Covid-19 pandemic#612062eScholarship
• Microbial sensing through the non-canonical inflammasome modulates airway type 2 immunity#612175eScholarship
• Genome‐wide analyses of Liberibacter species provides insights into evolution, phylogenetic relationships, and virulence factors#612109eScholarship
• Integrating research and surveillance to mitigate zoonotic disease risk in indigenous communities: Insights from an expert group meeting in Amazonas, Peru#418984PLOS
• Recent trends in the microbiology and antimicrobial susceptibility patterns of deep neck space infections, a descriptive analysis#451029WIReDSpace
• The effect of government information release on public protective behaviors during the emerging infectious diseases epidemic in China.#1133NCBI PubMed Central
• Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment#10192bioRxiv / medRxiv
• Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis#28392ClinicalTrials.gov
• Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature#67954bioRxiv / medRxiv
• Plasma proteomics identifies early markers of endothelial and inflammatory activation associated with dengue disease severity in children#67995bioRxiv / medRxiv
• Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus#121401ClinicalTrials.gov
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults#143655ClinicalTrials.gov
• Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation#143760ClinicalTrials.gov
• Antibody-drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges.#152247NCBI PubMed Central
• Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA#154690ClinicalTrials.gov
• Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults#154719ClinicalTrials.gov
• Development and Evaluation of an ARTIC-Based Amplicon Sequencing Assay for Whole-Genome Characterization of Respiratory Syncytial Virus#158276bioRxiv / medRxiv
• Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults#172389ClinicalTrials.gov
• A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes#217089ClinicalTrials.gov
• What will it take to achieve the End TB targets in South Africa? A mathematical modelling analysis#223943bioRxiv / medRxiv
• Vδ2 T cell activation by malaria is enhanced in second infection via the cell extrinsic cytokine milieu#241511bioRxiv / medRxiv
• Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)#253044ClinicalTrials.gov
• Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge#287382ClinicalTrials.gov
• Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants#290765bioRxiv / medRxiv
• Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali#311202ClinicalTrials.gov
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems#332791ClinicalTrials.gov
• Recommendation of: Optimizing telework in an epidemic context: contrasting the infectious and non-communicable diseases perspectives. Round#2#343177HAL (France)
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)#353320ClinicalTrials.gov
• Crimean-Congo haemorrhagic fever virus transmission: exploring perceptions of human-animal-tick interactions across six districts in Uganda#359684bioRxiv / medRxiv
• Immune organoids for Africa: a roadmap for bridging the innovation gap in infectious diseases and cancer research.#375293NCBI PubMed Central
• Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza#411261ClinicalTrials.gov
• Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine#417597ClinicalTrials.gov
• EpiControl: a data-driven tool for optimising epidemic interventions and automating scenario planning to support real-time response#419972bioRxiv / medRxiv
• Clinical Impact, Diagnostic Performance, and Prognostic Implications of Plasma Metagenomic Next-Generation Sequencing in Solid Organ Transplant Recipients#424135bioRxiv / medRxiv
• Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands#456075Springer Nature OA
• Rationale and guidance for implementing the continual reassessment method for dose-finding in controlled human infection model studies#456620bioRxiv / medRxiv
• Development and external validation of a multivariable regression model for bacteraemia in adults presenting to emergency departments#459894bioRxiv / medRxiv
• Impact of subgroup classification accuracy on detecting heterogeneous treatment effects in Staphylococcus aureus bacteraemia: A simulation study#463569bioRxiv / medRxiv
• Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine‐containing regimen: Case report and review of the literature#491875eScholarship
• 42 U.S.C. § 300ff-132 — Routine notifications with respect to airborne infectious diseases in victims assisted#594617US Code (LII)
• Exploring how older adults perceived the impact of infectious diseases and vaccines on ageing: a cross-sectional study in France#7821HAL (France)
• Uncloaking the black-box: the need for explainable artificial intelligence in clinical microbiology and infectious diseases applications.#25655NCBI PubMed Central